Synthetic challenges in the development of commercial manufacturing processes for two active pharmaceutical ingredients

被引:0
|
作者
Savage, Scott [2 ]
Domagalski, Nathan [2 ]
Hobson, Lindsay [1 ]
Jones, Scott [1 ]
Mack, Brendan [2 ]
Qiu, Yuping [2 ]
Ramirez, Antonio [2 ]
Waltermire, Robert [2 ]
机构
[1] Bristol Myers Squibb, New Brunswick, NJ USA
[2] Bristol Myers Squibb, Chem & Synthet Dev, New Brunswick, NJ USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
558
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Continuous-Flow TechnologyA Tool for the Safe Manufacturing of Active Pharmaceutical Ingredients
    Gutmann, Bernhard
    Cantillo, David
    Kappe, C. Oliver
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2015, 54 (23) : 6688 - 6728
  • [32] Current Good Manufacturing Practice Design Trends in Active Pharmaceutical Ingredients Facilities
    Louis A. Angelucci
    Drug information journal : DIJ / Drug Information Association, 1999, 33 : 739 - 746
  • [33] A RISK-BASED APPROACH TO MANAGING ACTIVE PHARMACEUTICAL INGREDIENTS IN MANUFACTURING EFFLUENT
    Caldwell, Daniel J.
    Mertens, Birgit
    Kappler, Kelly
    Senac, Thomas
    Journel, Romain
    Wilson, Peter
    Meyerhoff, Roger D.
    Parke, Neil J.
    Mastrocco, Frank
    Mattson, Bengt
    Murray-Smith, Richard
    Dolan, David G.
    Straub, Juerg Oliver
    Wiedemann, Michael
    Hartmann, Andreas
    Finan, Douglas S.
    ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 2016, 35 (04) : 813 - 822
  • [34] Asymmetric organocatalysis in drug discovery and development for active pharmaceutical ingredients
    Burke, Anthony J.
    EXPERT OPINION ON DRUG DISCOVERY, 2023, 18 (01) : 37 - 46
  • [35] Olefin metathesis: a versatile synthetic tool for use in preparation of Active Pharmaceutical Ingredients
    Olszewski, Tomasz K.
    Figlus, Marek
    Bieniek, Michal
    CHIMICA OGGI-CHEMISTRY TODAY, 2014, 32 (05) : 22 - +
  • [36] GMP requirements for quality control/assurance in the manufacturing of active pharmaceutical ingredients examples from manufacturing plants
    Schönborn, C
    PHARMAZEUTISCHE INDUSTRIE, 2003, 65 (07): : 695 - +
  • [37] Development of active pharmaceutical ingredients for clinical development: Synthesis of a gamma secretase modulator
    Caron, Stephane
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [38] Active Pharmaceutical Ingredients Transportation and Release from Aerogel Particles Processes Modeling
    Lebedev, Igor
    Uvarova, Anastasia
    Mochalova, Maria
    Menshutina, Natalia
    COMPUTATION, 2022, 10 (08)
  • [39] The role of microbiology in the design and development of pharmaceutical manufacturing processes
    Lolas, Anastasia
    PHARMACEUTICAL BIOPROCESSING, 2014, 2 (02) : 125 - 128
  • [40] Enabling precision manufacturing of active pharmaceutical ingredients: workflow for seeded cooling continuous crystallisations
    Brown, Cameron J.
    McGlone, Thomas
    Yerdelen, Stephanie
    Srirambhatla, Vijay
    Mabbott, Fraser
    Gurung, Rajesh
    Briuglia, Maria L.
    Ahmed, Bilal
    Polyzois, Hector
    McGinty, John
    Perciballi, Francesca
    Fysikopoulos, Dimitris
    MacFhionnghaile, Pol
    Siddique, Humera
    Raval, Vishal
    Harrington, Tomas S.
    Vassileiou, Antony D.
    Robertson, Murray
    Prasad, Elke
    Johnston, Andrea
    Johnston, Blair
    Nordon, Alison
    Srai, Jagjit S.
    Halbert, Gavin
    ter Horst, Joop H.
    Price, Chris J.
    Rielly, Chris D.
    Sefcik, Jan
    Florence, Alastair J.
    MOLECULAR SYSTEMS DESIGN & ENGINEERING, 2018, 3 (03): : 518 - 549